Endpoints News

Vinay Prasad to exit FDA again, following latest round of controversy

Vinay Prasad, the controversial head of the FDA’s vaccines and biologics division, will leave the agency, a government official confirmed to Endpoints News.

This report was first published by Endpoints News. To see the original version, click here

Vinay Prasad, the controversial head of the FDA’s vaccines and biologics division, will leave the agency, a government official confirmed to Endpoints News.

It’s the second time Prasad has left the FDA, after a tumultuous tenure that has spanned much of the Trump administration. Over and over again, Prasad has found himself at the center of controversial decisions, such as overruling staff on a flu vaccine.

您已阅读15%(499字),剩余85%(2926字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×